{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:12:09Z","timestamp":1792764729599,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-024-01523-z","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T01:03:55Z","timestamp":1735261435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Differences in Blood and Cerebrospinal Fluid Between Parkinson\u2019s Disease and Related Diseases"],"prefix":"10.1007","volume":"45","author":[{"given":"Jie","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","first-page":"430.e1","DOI":"10.1016\/j.neurobiolaging.2010.12.001","volume":"33","author":"MB Aerts","year":"2012","unstructured":"Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM (2012) CSF \u03b1-synuclein does not differentiate between Parkinsonian disorders. Neurobiol Aging 33:430.e1-430.e3. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.12.001","journal-title":"Neurobiol Aging"},{"key":"1523_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105698","volume":"168","author":"J Amin","year":"2022","unstructured":"Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, McKeith IG, O\u2019Brien JT, Teeling JL, Thomas AJ (2022) Inflammation in dementia with Lewy bodies. Neurobiol Dis 168:105698. https:\/\/doi.org\/10.1016\/j.nbd.2022.105698","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1523_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.10569810.1212\/WNL.0000000000209818","volume":"103","author":"C Anastassiadis","year":"2024","unstructured":"Anastassiadis C, Martinez-Valbuena I, Vasilevskaya A, Thapa S, Hadian M, Morales-Rivero A, Mora-Fisher D, Salvo C, Taghdiri F, Sato C, Moreno D, Anor CJ, Misquitta K, Couto B, Tang-Wai DF, Lang AE, Fox SH, Rogaeva E, Kovacs GG, Tartaglia MC (2024) CSF \u03b1-synuclein seed amplification assay in patients with atypical Parkinsonian disorders. Neurology 103(6):e209818. https:\/\/doi.org\/10.1016\/j.nbd.2022.10569810.1212\/WNL.0000000000209818","journal-title":"Neurology"},{"key":"1523_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100713","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Paudel YN, Villa C, Piperi C (2020) Arylsulfatase A (ASA) in Parkinson\u2019s disease: from pathogenesis to biomarker potential. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci10100713","journal-title":"Brain Sci"},{"key":"1523_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"1523_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55\u201359. https:\/\/doi.org\/10.1159\/000112832","journal-title":"Neurodegener Dis"},{"key":"1523_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mds.29257","volume":"38","author":"M Bartl","year":"2023","unstructured":"Bartl M, Dakna M, Schade S, Otte B, Wicke T, Lang E, Starke M, Ebentheuer J, Weber S, Toischer K, Schnelle M, Sixel-D\u00f6ring F, Trenkwalder C, Mollenhauer B (2023) Blood markers of inflammation, neurodegeneration, and cardiovascular risk in early Parkinson\u2019s disease. Mov Disord 38:68\u201381. https:\/\/doi.org\/10.1002\/mds.29257","journal-title":"Mov Disord"},{"key":"1523_CR8","doi-asserted-by":"publisher","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group, Alvarez-Cerme\u00f1o JC, Andreasson U, Axelsson M, B\u00e4ckstr\u00f6m DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialov\u00e1 L, Forsgren L, Frederiksen JL, Gissl\u00e9n M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Land\u00e9n M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, P\u00e9rez-Santiago J, Piehl F, Pijnenburg YAL, Pyykk\u00f6 OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillb\u00e4ck T, Stilund M, Sundstr\u00f6m P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, V\u00e5gberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkels\u00f8 C, Wild EJ (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035\u20131048. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534","DOI":"10.1001\/jamaneurol.2019.1534"},{"issue":"1","key":"1523_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jviromet.2009.02.019","volume":"159","author":"B Chang","year":"2009","unstructured":"Chang B, Gray P, Piltch M, Bulgin MS, Sorensen-Melson S, Miller MW, Davies P, Brown DR, Coughlin DR, Rubenstein R (2009) Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection. J Virol Methods 159(1):15\u201322. https:\/\/doi.org\/10.1016\/j.jviromet.2009.02.019","journal-title":"J Virol Methods"},{"issue":"1","key":"1523_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-024-00664-8","volume":"10","author":"N Che","year":"2024","unstructured":"Che N, Ou R, Li C, Zhang L, Wei Q, Wang S, Jiang Q, Yang T, Xiao Y, Lin J, Zhao B, Chen X, Shang H (2024) Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):48. https:\/\/doi.org\/10.1038\/s41531-024-00664-8","journal-title":"NPJ Parkinsons Dis"},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2022.02.006","volume":"529","author":"R Chen","year":"2022","unstructured":"Chen R, Gu X, Wang X (2022a) \u03b1-synuclein in Parkinson\u2019s disease and advances in detection. Clin Chim Acta 529:76\u201386. https:\/\/doi.org\/10.1016\/j.cca.2022.02.006","journal-title":"Clin Chim Acta"},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bj.2021.12.010","volume":"45","author":"WR Chen","year":"2022","unstructured":"Chen WR, Chen JC, Chang SY, Chao CT, Wu YR, Chen CM, Chou C (2022b) Phosphorylated \u03b1-synuclein in diluted human serum as a biomarker for Parkinson\u2019s disease. Biomed J 45:914\u2013922. https:\/\/doi.org\/10.1016\/j.bj.2021.12.010","journal-title":"Biomed J"},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L (2017) Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther 9:52. https:\/\/doi.org\/10.1186\/s13195-017-0276-4","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1523_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18(4):1179\u20131196. https:\/\/doi.org\/10.1038\/s41596-022-00787-3","journal-title":"Nat Protoc"},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jns.2017.09.039","volume":"382","author":"VC Constantinides","year":"2017","unstructured":"Constantinides VC, Paraskevas GP, Emmanouilidou E, Petropoulou O, Bougea A, Vekrellis K, Evdokimidis I, Stamboulis E, Kapaki E (2017) CSF biomarkers beta-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes. J Neurol Sci 382:91\u201395. https:\/\/doi.org\/10.1016\/j.jns.2017.09.039","journal-title":"J Neurol Sci"},{"key":"1523_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/brainsci11010119","volume":"11","author":"VC Constantinides","year":"2021","unstructured":"Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E (2021) Cerebrospinal fluid alpha-synuclein species in cognitive and movements disorders. Brain Sci 11:119. https:\/\/doi.org\/10.3390\/brainsci11010119","journal-title":"Brain Sci"},{"key":"1523_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, Serrano GE, Adler CH, Perlman SL, Poon WW, Kang UJ, Alcalay RN, Sklerov M, Gylys KH, Kaufmann H, Fogel BL, Bronstein JM, Ritz B, Bitan G (2021) \u03b1-synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol 142:495\u2013511. https:\/\/doi.org\/10.1007\/s00401-021-02324-0","journal-title":"Acta Neuropathol"},{"key":"1523_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105966","volume":"176","author":"J Estaun-Panzano","year":"2023","unstructured":"Estaun-Panzano J, Arotcarena ML, Bezard E (2023) Monitoring \u03b1-synuclein aggregation. Neurobiol Dis 176:105966. https:\/\/doi.org\/10.1016\/j.nbd.2022.105966","journal-title":"Neurobiol Dis"},{"key":"1523_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L (2017) Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 32:1389\u20131400. https:\/\/doi.org\/10.1002\/mds.27110","journal-title":"Mov Disord"},{"key":"1523_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MTM, Parkkinen L, Green AJE (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"key":"1523_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105807","volume":"117","author":"B Fernandes Gomes","year":"2023","unstructured":"Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Lebovitz R, Nellg\u00e5rd B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, Andreasson U, Zetterberg H, Blennow K (2023) \u03b1-Synuclein seed amplification assay as a diagnostic tool for Parkinsonian disorders. Parkinsonism Relat Disord 117:105807. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105807","journal-title":"Parkinsonism Relat Disord"},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ene.14032","volume":"27","author":"MG F\u00f8rland","year":"2020","unstructured":"F\u00f8rland MG, Tysnes OB, Aarsland D, Maple-Gr\u00f8dem J, Pedersen KF, Alves G, Lange J (2020) The value of cerebrospinal fluid \u03b1-synuclein and the tau\/\u03b1-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology. Eur J Neurol 27:43\u201350. https:\/\/doi.org\/10.1111\/ene.14032","journal-title":"Eur J Neurol"},{"key":"1523_CR23","doi-asserted-by":"publisher","unstructured":"Gautam G, Singh H (2024) Biomarkers in dementia research. In: Moradikor N, Chatterjee I, Mohamed W (eds) Nutrition in brain aging and dementia. Springer, Singapore, pp 93\u2013107. https:\/\/doi.org\/10.1007\/978-981-97-4117-5_4","DOI":"10.1007\/978-981-97-4117-5_4"},{"issue":"6","key":"1523_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/mas.21599","volume":"38","author":"FP Gomes","year":"2019","unstructured":"Gomes FP, Yates JR (2019) Recent trends of capillary electrophoresis-mass spectrometry in proteomics research. Mass Spectrom Rev 38(6):445\u2013460. https:\/\/doi.org\/10.1002\/mas.21599","journal-title":"Mass Spectrom Rev"},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"1210220","DOI":"10.3389\/fneur.2023.1210220","volume":"14","author":"M Goolla","year":"2023","unstructured":"Goolla M, Cheshire WP, Ross OA, Kondru N (2023) Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers. Front Neurol 14:1210220. https:\/\/doi.org\/10.3389\/fneur.2023.1210220","journal-title":"Front Neurol"},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"16272","DOI":"10.1038\/s41598-023-43096-9","volume":"13","author":"D Gu\u00e9vremont","year":"2023","unstructured":"Gu\u00e9vremont D, Roy J, Cutfield NJ, Williams JM (2023) MicroRNAs in Parkinson\u2019s disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep 13:16272. https:\/\/doi.org\/10.1038\/s41598-023-43096-9","journal-title":"Sci Rep"},{"issue":"5","key":"1523_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14124","volume":"23","author":"T Guo","year":"2024","unstructured":"Guo T, Zhou L, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang Z-H, Xiao T, Hu D, Bao A, Zhang Z (2024) N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson\u2019s disease. Aging Cell 23(5):e14124. https:\/\/doi.org\/10.1111\/acel.14124","journal-title":"Aging Cell"},{"issue":"1","key":"1523_CR28","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"S Hall","year":"2018","unstructured":"Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O (2018) Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical Parkinsonian disorders. Sci Rep 8(1):13276. https:\/\/doi.org\/10.1038\/s41598-018-31517-z","journal-title":"Sci Rep"},{"key":"1523_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Swedish BioFINDER Study (2017) Blood-based NfL: a biomarker for differential diagnosis of Parkinsonian disorder. Neurology 88:930\u2013937. https:\/\/doi.org\/10.1212\/WNL.0000000000003680","journal-title":"Neurology"},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2023.13621","volume":"330","author":"E Harris","year":"2023","unstructured":"Harris E (2023) Identifying Lewy body disease before symptoms. JAMA 330:686. https:\/\/doi.org\/10.1001\/jama.2023.13621","journal-title":"JAMA"},{"key":"1523_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12383","volume":"12","author":"Y Hirschberg","year":"2023","unstructured":"Hirschberg Y, Valle-Tamayo N, Dols-Icardo O, Engelborghs S, Buelens B, Vandenbroucke RE, Vermeiren Y, Boonen K, Mertens I (2023) Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer\u2019s, Parkinson\u2019s and Lewy body dementia. J Extracell Vesicles 12:e12383. https:\/\/doi.org\/10.1002\/jev2.12383","journal-title":"J Extracell Vesicles"},{"key":"1523_CR32","doi-asserted-by":"publisher","unstructured":"Holm H, Gundersen V, Dietrichs E (2023) Vascular parkinsonism. Tidsskr Nor Laegeforen 143. https:\/\/doi.org\/10.4045\/tidsskr.22.0539","DOI":"10.4045\/tidsskr.22.0539"},{"issue":"18","key":"1523_CR33","doi-asserted-by":"publisher","first-page":"e2332","DOI":"10.1212\/WNL.0000000000011853","volume":"96","author":"Z Hong","year":"2021","unstructured":"Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, Sheng L, Borden K, Khrisat T, Pan C, Zabetian CP, Peskind ER, Quinn JF, Montine TJ, Aasly J, Shi M, Zhang J (2021) Development of a sensitive diagnostic assay for Parkinson disease quantifying \u03b1-synuclein-containing extracellular vesicles. Neurology 96(18):e2332\u2013e2345. https:\/\/doi.org\/10.1212\/WNL.0000000000011853","journal-title":"Neurology"},{"key":"1523_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12883-022-02558-9","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Huang C, Zhang Q, Shen T, Sun J (2022) Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity. BMC Neurol 22:39. https:\/\/doi.org\/10.1186\/s12883-022-02558-9","journal-title":"BMC Neurol"},{"key":"1523_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377\u2013387. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347","journal-title":"JAMA Neurol"},{"key":"1523_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biochi.2015.09.023","volume":"122","author":"M Kalinska","year":"2016","unstructured":"Kalinska M, Meyer-Hoffert U, Kantyka T, Potempa J (2016) Kallikreins\u2014the melting pot of activity and function. Biochimie 122:270\u2013282. https:\/\/doi.org\/10.1016\/j.biochi.2015.09.023","journal-title":"Biochimie"},{"key":"1523_CR37","doi-asserted-by":"publisher","first-page":"17037","DOI":"10.3390\/ijms242317037","volume":"24","author":"I Kawahata","year":"2023","unstructured":"Kawahata I, Fukunaga K (2023) Pathogenic impact of fatty acid-binding proteins in Parkinson\u2019s disease-potential biomarkers and therapeutic targets. Int J Mol Sci 24:17037. https:\/\/doi.org\/10.3390\/ijms242317037","journal-title":"Int J Mol Sci"},{"key":"1523_CR38","doi-asserted-by":"publisher","first-page":"13267","DOI":"10.3390\/ijms241713267","volume":"24","author":"I Kawahata","year":"2023","unstructured":"Kawahata I, Sekimori T, Oizumi H, Takeda A, Fukunaga K (2023) Using fatty acid-binding proteins as potential biomarkers to discriminate between Parkinson\u2019s disease and dementia with Lewy bodies: exploration of a novel technique. Int J Mol Sci 24:13267. https:\/\/doi.org\/10.3390\/ijms241713267","journal-title":"Int J Mol Sci"},{"key":"1523_CR39","doi-asserted-by":"publisher","first-page":"17191","DOI":"10.1038\/s41598-023-43956-4","volume":"13","author":"J Kelly","year":"2023","unstructured":"Kelly J, Moyeed R, Carroll C, Luo S, Li X (2023) Blood biomarker-based classification study for neurodegenerative diseases. Sci Rep 13:17191. https:\/\/doi.org\/10.1038\/s41598-023-43956-4","journal-title":"Sci Rep"},{"issue":"s2","key":"1523_CR40","doi-asserted-by":"publisher","first-page":"S323","DOI":"10.3233\/JPD-230429","volume":"14","author":"A Kluge","year":"2024","unstructured":"Kluge A, Iranzo A (2024) Biofluid detection of pathological \u03b1-synuclein in the prodromal phase of synucleinopathies. Journal of Parkinson\u2019s Disease 14(s2):S323\u2013S331. https:\/\/doi.org\/10.3233\/JPD-230429","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"9","key":"1523_CR41","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A, Bunk J, Schaeffer E, Drobny A, Xiang W, Knacke H, Bub S, L\u00fcckst\u00e4dt W, Arnold P, Lucius R, Berg D, Zunke F (2022) Detection of neuron-derived pathological \u03b1-synuclein in blood. Brain 145(9):3058\u20133071. https:\/\/doi.org\/10.1093\/brain\/awac115","journal-title":"Brain"},{"key":"1523_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.15944","volume":"167","author":"D Kon\u00ed\u010dkov\u00e1","year":"2023","unstructured":"Kon\u00ed\u010dkov\u00e1 D, Men\u0161\u00edkov\u00e1 K, Kl\u00ed\u010dov\u00e1 K, Chud\u00e1\u010dkov\u00e1 M, Kaiserov\u00e1 M, P\u0159ikrylov\u00e1 H, Otruba P, Nevrl\u00fd M, Hlu\u0161t\u00edk P, H\u00e9nykov\u00e1 E, Kaleta M, Friedeck\u00fd D, Mat\u011bj R, Strnad M, Nov\u00e1k O, Pl\u00edhalov\u00e1 L, Rosales R, Colosimo C, Ka\u0148ovsk\u00fd P (2023) Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: a prospective, open, cross-correlation study. J Neurochem 167:168\u2013182. https:\/\/doi.org\/10.1111\/jnc.15944","journal-title":"J Neurochem"},{"key":"1523_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121813","author":"B Kosmowska","year":"2021","unstructured":"Kosmowska B, Wardas J (2021) The pathophysiology and treatment of essential tremor: the role of adenosine and dopamine receptors in animal models. Biomolecules. https:\/\/doi.org\/10.3390\/biom11121813","journal-title":"Biomolecules"},{"key":"1523_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/psyg.12483","volume":"20","author":"J Li","year":"2020","unstructured":"Li J, Gu C, Zhu M, Li D, Chen L, Zhu X (2020a) Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson\u2019s disease. Psychogeriatrics 20:180\u2013188. https:\/\/doi.org\/10.1111\/psyg.12483","journal-title":"Psychogeriatrics"},{"issue":"6","key":"1523_CR45","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang X-X, Truong D, Wu Y-C (2020b) The critical role of SIRT1 in parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis 11(6):1608\u20131622. https:\/\/doi.org\/10.14336\/AD.2020.0216","journal-title":"Aging Dis"},{"key":"1523_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.107595","volume":"225","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang C, Xu W, Chen J, Tuo J, Wen Y, Huang Z, Zeng R (2023) Serum Sirtuin1 level decreases in Parkinson\u2019s disease and vascular parkinsonism: a prospective observational study. Clin Neurol Neurosurg 225:107595. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107595","journal-title":"Clin Neurol Neurosurg"},{"key":"1523_CR47","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.3390\/ijms21186914","volume":"21","author":"CH Lin","year":"2020","unstructured":"Lin CH, Chiu SI, Chen TF, Jang JR, Chiu MJ (2020) Classifications of neurodegenerative disorders using a multiplex blood biomarkers-based machine learning model. Int J Mol Sci 21:6914. https:\/\/doi.org\/10.3390\/ijms21186914","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1523_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q, Pang D, Liu K, Jiang Q, Yang T, Xiao Y, Zhao B, Chen X, Song W, Yang J, Wu Y, Shang H (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21(1):420. https:\/\/doi.org\/10.1186\/s12916-023-03120-1","journal-title":"BMC Med"},{"key":"1523_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O (2013) Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease\u2014associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 33:183\u2013189. https:\/\/doi.org\/10.1016\/j.bbi.2013.07.007","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1523_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.31083\/j.jin2205115","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Gou M, Guo X (2023) Features of plasma homocysteine, vitamin B12, and folate in Parkinson\u2019s disease: an updated meta-analysis. J Integr Neurosci 22(5):115. https:\/\/doi.org\/10.31083\/j.jin2205115","journal-title":"J Integr Neurosci"},{"key":"1523_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2024.08.006","author":"H Luo","year":"2024","unstructured":"Luo H, Yu X, Li P, Hu J, Li W, Li X, Chen M, Yu S (2024) Different neurotoxicity and seeding activity between \u03b1-synuclein oligomers formed in plasma of patients with Parkinson\u2019s disease and multiple system atrophy. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.006","journal-title":"Neuroscience"},{"key":"1523_CR52","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.14336\/AD.2023.1005","volume":"15","author":"Z-L Ma","year":"2024","unstructured":"Ma Z-L, Wang Z-L, Zhang F-Y, Liu H-X, Mao L-H, Yuan L (2024) Biomarkers of Parkinson\u2019s disease: from basic research to clinical practice. Aging Dis 15:1813\u20131830. https:\/\/doi.org\/10.14336\/AD.2023.1005","journal-title":"Aging Dis"},{"issue":"2","key":"1523_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1567202619666220602125806","volume":"19","author":"K Maiese","year":"2022","unstructured":"Maiese K (2022) Biomarkers for Parkinson\u2019s disease and neurodegenerative disorders: a role for non-coding RNAs. Curr Neurovasc Res 19(2):127\u2013130. https:\/\/doi.org\/10.2174\/1567202619666220602125806","journal-title":"Curr Neurovasc Res"},{"key":"1523_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","volume":"11","author":"NK Majbour","year":"2016","unstructured":"Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB, Montezinho LP, Poole S, Safieh-Garabedian B, Tokuda T, Teunissen CE, Berendse HW, van de Berg WDJ, El-Agnaf OMA (2016) Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease. Mol Neurodegener 11:7. https:\/\/doi.org\/10.1186\/s13024-016-0072-9","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1523_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-020-00192-4","volume":"9","author":"NK Majbour","year":"2020","unstructured":"Majbour NK, Aasly JO, Hustad E, Thomas MA, Vaikath NN, Elkum N, van de Berg WDJ, Tokuda T, Mollenhauer B, Berendse HW, El-Agnaf OMA (2020) CSF total and oligomeric \u03b1-Synuclein along with TNF-\u03b1 as risk biomarkers for Parkinson\u2019s disease: a study in LRRK2 mutation carriers. Transl Neurodegener 9(1):15. https:\/\/doi.org\/10.1186\/s40035-020-00192-4","journal-title":"Transl Neurodegener"},{"issue":"15","key":"1523_CR56","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1021\/acs.analchem.4c00477","volume":"96","author":"DM Makey","year":"2024","unstructured":"Makey DM, Gadkari VV, Kennedy RT, Ruotolo BT (2024) Cyclic ion mobility-mass spectrometry and tandem collision induced unfolding for quantification of elusive protein biomarkers. Anal Chem 96(15):6021\u20136029. https:\/\/doi.org\/10.1021\/acs.analchem.4c00477","journal-title":"Anal Chem"},{"key":"1523_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","volume":"11","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Visanji NP, Kim A, Lau HHC, So RWL, Alshimemeri S, Gao A, Seidman MA, Luquin MR, Watts JC, Lang AE, Kovacs GG (2022) Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy. Transl Neurodegener 11:7. https:\/\/doi.org\/10.1186\/s40035-022-00283-4","journal-title":"Transl Neurodegener"},{"key":"1523_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010060","author":"I Mavroudis","year":"2021","unstructured":"Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, Luca IS, Ciobica A, Kazis D (2021) YKL-40 as a potential biomarker for the differential diagnosis of Alzheimer\u2019s disease. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina58010060","journal-title":"Medicina (Kaunas)"},{"key":"1523_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105947","volume":"176","author":"M Meloni","year":"2023","unstructured":"Meloni M, Agliardi C, Guerini FR, Zanzottera M, Bolognesi E, Picciolini S, Marano M, Magliozzi A, Di Fonzo A, Arighi A, Fenoglio C, Franco G, Arienti F, Saibene FL, Navarro J, Clerici M (2023) Oligomeric \u03b1-synuclein and tau aggregates in NDEVs differentiate Parkinson\u2019s disease from atypical Parkinsonisms. Neurobiol Dis 176:105947. https:\/\/doi.org\/10.1016\/j.nbd.2022.105947","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1523_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10286-020-00680-7","volume":"30","author":"MG Miglis","year":"2020","unstructured":"Miglis MG, Muppidi S (2020) Synuclein in red blood cells: a potential biomarker for multiple system atrophy, and other updates on recent autonomic research. Clin Auton Res 30(2):107\u2013109. https:\/\/doi.org\/10.1007\/s10286-020-00680-7","journal-title":"Clin Auton Res"},{"issue":"1","key":"1523_CR61","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1038\/s41598-019-44173-8","volume":"9","author":"E Morenas-Rodr\u00edguez","year":"2019","unstructured":"Morenas-Rodr\u00edguez E, Alcolea D, Su\u00e1rez-Calvet M, Mu\u00f1oz-Llahuna L, Vilaplana E, Sala I, Subirana A, Querol-Vilaseca M, Carmona-Iragui M, Ill\u00e1n-Gala I, Ribosa-Nogu\u00e9 R, Blesa R, Haass C, Fortea J, Lle\u00f3 A (2019) Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer\u2019s disease. Sci Rep 9(1):7803. https:\/\/doi.org\/10.1038\/s41598-019-44173-8","journal-title":"Sci Rep"},{"key":"1523_CR62","doi-asserted-by":"publisher","first-page":"1310094","DOI":"10.3389\/fimmu.2023.1310094","volume":"14","author":"EE Neumaier","year":"2023","unstructured":"Neumaier EE, Rothhammer V, Linnerbauer M (2023) The role of midkine in health and disease. Front Immunol 14:1310094. https:\/\/doi.org\/10.3389\/fimmu.2023.1310094","journal-title":"Front Immunol"},{"key":"1523_CR63","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno SI, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, G\u00e9rardy JJ, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29:1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","journal-title":"Nat Med"},{"key":"1523_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105968","volume":"121","author":"C Painous","year":"2024","unstructured":"Painous C, Fern\u00e1ndez M, P\u00e9rez J, de Mena L, C\u00e1mara A, Compta Y (2024) Fluid and tissue biomarkers in Parkinson\u2019s disease: immunodetection or seed amplification? Central or peripheral? Parkinsonism Relat Disord 121:105968. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105968","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1523_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41531-023-00509-w","volume":"9","author":"F Paolini Paoletti","year":"2023","unstructured":"Paolini Paoletti F, Gaetani L, Bellomo G, Chipi E, Salvadori N, Montanucci C, Mancini A, Filidei M, Nigro P, Simoni S, Tambasco N, Di Filippo M, Parnetti L (2023) CSF neurochemical profile and cognitive changes in Parkinson\u2019s disease with mild cognitive impairment. NPJ Parkinson\u2019s Dis 9(1):68. https:\/\/doi.org\/10.1038\/s41531-023-00509-w","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"1523_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P (2019) CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18:573\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"key":"1523_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","volume":"12","author":"W Paslawski","year":"2023","unstructured":"Paslawski W, Khosousi S, Hertz E, Markaki I, Boxer A, Svenningsson P (2023) Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson\u2019s disease. Transl Neurodegener 12:42. https:\/\/doi.org\/10.1186\/s40035-023-00374-w","journal-title":"Transl Neurodegener"},{"key":"1523_CR68","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, Parchi P, Mattsson-Carlgren N, Janelidze S, Hansson O (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3:1201\u20131209. https:\/\/doi.org\/10.1038\/s43587-023-00478-y","journal-title":"Nat Aging"},{"issue":"1","key":"1523_CR69","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/acs.analchem.9b04802","volume":"92","author":"R Pero-Gascon","year":"2020","unstructured":"Pero-Gascon R, Benavente F, Minic Z, Berezovski MV, Sanz-Nebot V (2020) On-line aptamer affinity solid-phase extraction capillary electrophoresis-mass spectrometry for the analysis of blood \u03b1-synuclein. Anal Chem 92(1):1525\u20131533. https:\/\/doi.org\/10.1021\/acs.analchem.9b04802","journal-title":"Anal Chem"},{"key":"1523_CR70","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fneur.2019.00384","volume":"10","author":"X Qiu","year":"2019","unstructured":"Qiu X, Xiao Y, Wu J, Gan L, Huang Y, Wang J (2019) C-Reactive protein and risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 10:384. https:\/\/doi.org\/10.3389\/fneur.2019.00384","journal-title":"Front Neurol"},{"key":"1523_CR71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C, Giannini G, Candelise N, Sambati L, Polischi B, Plazzi G, Capellari S, Cortelli P, Parchi P (2021) Neurofilament light chain and alpha-synuclein RT-QuIC as differential diagnostic biomarkers in Parkinsonisms and related syndromes. NPJ Parkinsons Dis 7:93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinsons Dis"},{"key":"1523_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2023.341149","volume":"1256","author":"H Salim","year":"2023","unstructured":"Salim H, Pont L, Gim\u00e9nez E, Benavente F (2023) On-line aptamer affinity solid-phase extraction direct mass spectrometry for the rapid analysis of \u03b1-synuclein in blood. Anal Chim Acta 1256:341149. https:\/\/doi.org\/10.1016\/j.aca.2023.341149","journal-title":"Anal Chim Acta"},{"key":"1523_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C (2017) Development of a biochemical diagnosis of Parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163\u2013172. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4547","journal-title":"JAMA Neurol"},{"key":"1523_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai AL, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"5","key":"1523_CR75","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bcpt.12424","volume":"117","author":"M Sharma","year":"2015","unstructured":"Sharma M, Tiwari M, Tiwari RK (2015) Hyperhomocysteinemia: impact on neurodegenerative diseases. Basic Clin Pharmacol Toxicol 117(5):287\u2013296. https:\/\/doi.org\/10.1111\/bcpt.12424","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1523_CR76","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","volume":"14","author":"KH Shim","year":"2022","unstructured":"Shim KH, Kang MJ, Youn YC, An SSA, Kim S (2022) Alpha-synuclein: a pathological factor with Abeta and tau and biomarker in Alzheimer\u2019s disease. Alzheimers Res Ther 14:201. https:\/\/doi.org\/10.1186\/s13195-022-01150-0","journal-title":"Alzheimers Res Ther"},{"key":"1523_CR77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson\u2019s Progression Markers Initiative (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"key":"1523_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2024.2407718","author":"AM Silva","year":"2024","unstructured":"Silva AM, Hickford ES, Cutler P (2024) An immunoassay for the quantification of phosphorylated \u03b1-synuclein at serine 129 in human cerebrospinal fluid. Bioanalysis. https:\/\/doi.org\/10.1080\/17576180.2024.2407718","journal-title":"Bioanalysis"},{"key":"1523_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/bios11090305","author":"MS Soares","year":"2021","unstructured":"Soares MS, Vidal M, Santos NF, Costa FM, Marques C, Pereira SO, Leit\u00e3o C (2021) Immunosensing based on optical fiber technology: recent advances. Biosensors (Basel). https:\/\/doi.org\/10.3390\/bios11090305","journal-title":"Biosensors (Basel)"},{"key":"1523_CR80","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.archger.2013.04.015","volume":"57","author":"IU Song","year":"2013","unstructured":"Song IU, Kim JS, Park IS, Kim YD, Cho HJ, Chung SW, Lee KS (2013) Clinical significance of homocysteine (hcy) on dementia in Parkinson\u2019s disease (PD). Arch Gerontol Geriatr 57:288\u2013291. https:\/\/doi.org\/10.1016\/j.archger.2013.04.015","journal-title":"Arch Gerontol Geriatr"},{"key":"1523_CR81","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"TB Stoker","year":"2018","unstructured":"Stoker TB, Greenland JC (2018) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications, Brisbane"},{"key":"1523_CR82","doi-asserted-by":"publisher","first-page":"eabq5923","DOI":"10.1126\/scitranslmed.abq5923","volume":"15","author":"YJ Sung","year":"2023","unstructured":"Sung YJ, Yang C, Norton J, Johnson M, Fagan A, Bateman RJ, Perrin RJ, Morris JC, Farlow MR, Chhatwal JP, Schofield PR, Chui H, Wang F, Novotny B, Eteleeb A, Karch C, Schindler SE, Rhinn H, Johnson ECB, Oh HSH, Rutledge JE, Dammer EB, Seyfried NT, Wyss-Coray T, Harari O, Cruchaga C (2023) Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease. Sci Transl Med 15:eabq5923. https:\/\/doi.org\/10.1126\/scitranslmed.abq5923","journal-title":"Sci Transl Med"},{"key":"1523_CR83","doi-asserted-by":"publisher","first-page":"1192115","DOI":"10.3389\/fneur.2023.1192115","volume":"14","author":"HB Taha","year":"2023","unstructured":"Taha HB (2023) Rethinking the reliability and accuracy of biomarkers in CNS-originating EVs for Parkinson\u2019s disease and multiple system atrophy. Front Neurol 14:1192115. https:\/\/doi.org\/10.3389\/fneur.2023.1192115","journal-title":"Front Neurol"},{"key":"1523_CR84","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s00415-023-12093-3","volume":"271","author":"HB Taha","year":"2024","unstructured":"Taha HB, Bogoniewski A (2024) Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. J Neurol 271:1680\u20131706. https:\/\/doi.org\/10.1007\/s00415-023-12093-3","journal-title":"J Neurol"},{"key":"1523_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-023-00346-0","volume":"12","author":"HB Taha","year":"2023","unstructured":"Taha HB, Hornung S, Dutta S, Fenwick L, Lahgui O, Howe K, Elabed N, Del Rosario I, Wong DY, Duarte Folle A, Markovic D, Palma JA, Kang UJ, Alcalay RN, Sklerov M, Kaufmann H, Fogel BL, Bronstein JM, Ritz B, Bitan G (2023) Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener 12:14. https:\/\/doi.org\/10.1186\/s40035-023-00346-0","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1523_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","volume":"9","author":"Y Tang","year":"2023","unstructured":"Tang Y, Han L, Li S, Hu T, Xu Z, Fan Y, Liang X, Yu H, Wu J, Wang J (2023) Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinson\u2019s Disease 9(1):23. https:\/\/doi.org\/10.1038\/s41531-023-00447-7","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"1523_CR87","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris GK (2022) Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell Mol Life Sci 79:210. https:\/\/doi.org\/10.1007\/s00018-022-04240-2","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"1523_CR88","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SAS, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OMA (2010) Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75(20):1766\u20131772. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"key":"1523_CR89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"1523_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105358","volume":"158","author":"H-H Tsao","year":"2022","unstructured":"Tsao H-H, Huang C-G, Wu Y-R (2022) Detection and assessment of alpha-synuclein in Parkinson disease. Neurochem Int 158:105358. https:\/\/doi.org\/10.1016\/j.neuint.2022.105358","journal-title":"Neurochem Int"},{"key":"1523_CR91","doi-asserted-by":"publisher","first-page":"27290","DOI":"10.1074\/jbc.M114.569814","volume":"289","author":"A Umemoto","year":"2014","unstructured":"Umemoto A, Yagi H, So M, Goto Y (2014) High-throughput analysis of ultrasonication-forced amyloid fibrillation reveals the mechanism underlying the large fluctuation in the lag time. J Biol Chem 289:27290\u201327299. https:\/\/doi.org\/10.1074\/jbc.M114.569814","journal-title":"J Biol Chem"},{"key":"1523_CR92","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, De Iuliis A, Nicoletti A, Zappia M, Purrello M, Antonini A (2014) Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and multiple system atrophy. Front Cell Neurosci 8:156. https:\/\/doi.org\/10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"key":"1523_CR93","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JPD-201988","volume":"10","author":"DJ van Wamelen","year":"2020","unstructured":"van Wamelen DJ, Taddei RN, Calvano A, Titova N, Leta V, Shtuchniy I, Jenner P, Martinez-Martin P, Katunina E, Chaudhuri KR (2020) Serum uric acid levels and non-motor symptoms in Parkinson\u2019s disease. J Parkinsons Dis 10:1003\u20131010. https:\/\/doi.org\/10.3233\/JPD-201988","journal-title":"J Parkinsons Dis"},{"key":"1523_CR104","doi-asserted-by":"crossref","unstructured":"Valeriia O, Kuzyk Govert W, Somsen Rob, Haselberg Ana Val\u00e9ria, Colnaghi Simionato (2021) Separation\nTechniques Applied to Omics Sciences From Principles to Relevant Applications CE-MS for Proteomics and\nIntact Protein Analysis Springer International Publishing Cham 51\u201386","DOI":"10.1007\/978-3-030-77252-9_4"},{"key":"1523_CR94","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","volume":"69","author":"I Villar-Men\u00e9ndez","year":"2014","unstructured":"Villar-Men\u00e9ndez I, Porta S, Buira SP, Pereira-Veiga T, D\u00edaz-S\u00e1nchez S, Albasanz JL, Ferrer I, Mart\u00edn M, Barrachina M (2014) Increased striatal adenosine A2a receptor levels is an early event in Parkinson\u2019s disease-related pathology and it is potentially regulated by miR-34b. Neurobiol Dis 69:206\u2013214. https:\/\/doi.org\/10.1016\/j.nbd.2014.05.030","journal-title":"Neurobiol Dis"},{"key":"1523_CR95","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VMY, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J (2012) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci Transl Med 4:121ra20. https:\/\/doi.org\/10.1126\/scitranslmed.3002566","journal-title":"Sci Transl Med"},{"issue":"1","key":"1523_CR96","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-022-00431-7","volume":"8","author":"C Xiang","year":"2022","unstructured":"Xiang C, Cong S, Tan X, Ma S, Liu Y, Wang H, Cong S (2022) A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis 8(1):165. https:\/\/doi.org\/10.1038\/s41531-022-00431-7","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"1523_CR97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","volume":"81","author":"S Yan","year":"2024","unstructured":"Yan S, Jiang C, Janzen A, Barber TR, Seger A, Sommerauer M, Davis JJ, Marek K, Hu MT, Oertel WH, Tofaris GK (2024) Neuronally derived extracellular vesicle \u03b1-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease. JAMA Neurol 81:59\u201368. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4398","journal-title":"JAMA Neurol"},{"key":"1523_CR98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41531-023-00577-y","volume":"9","author":"SW Yoo","year":"2023","unstructured":"Yoo SW, Ha S, Lyoo CH, Kim Y, Yoo JY, Kim JS (2023) Exploring the link between essential tremor and Parkinson\u2019s disease. NPJ Parkinsons Dis 9:134. https:\/\/doi.org\/10.1038\/s41531-023-00577-y","journal-title":"NPJ Parkinsons Dis"},{"key":"1523_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.827493","volume":"14","author":"Z Yu","year":"2022","unstructured":"Yu Z, Liu G, Li Y, Arkin E, Zheng Y, Feng T (2022) Erythrocytic alpha-synuclein species for Parkinson\u2019s disease diagnosis and the correlations with clinical characteristics. Front Aging Neurosci 14:827493. https:\/\/doi.org\/10.3389\/fnagi.2022.827493","journal-title":"Front Aging Neurosci"},{"key":"1523_CR100","doi-asserted-by":"publisher","first-page":"1173074","DOI":"10.3389\/fneur.2023.1173074","volume":"14","author":"Z Yu","year":"2023","unstructured":"Yu Z, Liu G, Zheng Y, Huang G, Feng T (2023) Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson\u2019s disease. Front Neurol 14:1173074. https:\/\/doi.org\/10.3389\/fneur.2023.1173074","journal-title":"Front Neurol"},{"key":"1523_CR101","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JPD-201912","volume":"10","author":"A Zhao","year":"2020","unstructured":"Zhao A, Li Y, Niu M, Li G, Luo N, Zhou L, Kang W, Liu J (2020) SNCA hypomethylation in rapid eye movement sleep behavior disorder is a potential biomarker for Parkinson\u2019s disease. J Parkinsons Dis 10:1023\u20131031. https:\/\/doi.org\/10.3233\/JPD-201912","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"1523_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14420","volume":"30","author":"L Zhou","year":"2024","unstructured":"Zhou L (2024) Homocysteine and Parkinson\u2019s disease. CNS Neurosci Ther 30(2):e14420. https:\/\/doi.org\/10.1111\/cns.14420","journal-title":"CNS Neurosci Ther"},{"key":"1523_CR103","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","volume":"99","author":"M Zubelzu","year":"2022","unstructured":"Zubelzu M, Morera-Herreras T, Irastorza G, G\u00f3mez-Esteban JC, Murueta-Goyena A (2022) Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord 99:107\u2013115. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.001","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-024-01523-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-024-01523-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-024-01523-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:23:46Z","timestamp":1765535026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-024-01523-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1007\/s10571-024-01523-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4973615\/v1","asserted-by":"object"}]},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author LH was employed by ICON Plc. The remaining authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read and approved the final version of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"9"}}